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Incidence of Invasive Cancers Following Squamous Cell Skin Cancer
Fabio Levi,1 Lalao Randimbison,1 Carlo La Vecchia,2 Georges Erler,1 and Van-Cong Te1
The authors describe the incidence of new primary cancers among 4,639 cases of squamous cell skin
cancer (SCC) diagnosed between 1974 and 1994 in the cancer registries of the Swiss cantons of Vaud and
Neuchatel (total person-years at risk = 23,152). Overall, 729 metachronous cancers were observed versus
527.6 expected, corresponding to a standardized incidence ratio (SIR) of 1.4 (95% confidence interval (Cl)
1.3-1.5). After exclusion of skin cancers, however, 384 second primary neoplasms were observed versus
397.2 expected (SIR = 1.0). Excesses were observed for cancers of the lip (SIR = 3.1) and lung (SIR = 1.3),
for basal cell (SIR = 4.3) and melanomatous skin cancers (SIR = 3.3), and non-Hodgkin's lymphomas (SIR =
1.7). Rates were elevated for cancers of the salivary glands (SIR = 4.3) and for Hodgkin's disease (SIR = 2.7),
and, below age 65 years, for cancers of the lung (SIR = 1.6), breast (SIR = 1.5), and prostate (SIR = 1.8), for
Hodgkin's disease (SIR = 15.8), as well as for all neoplasms except skin (SIR = 1.2; 95% Cl 1.0-1.5). The
cumulative risk of basal cell skin cancer reached 17% after 15 years. The authors believe that the excesses
for basal cell carcinomas and melanomas of the skin following SCC, and possibly of lymphomas, were likely
attributable to common phenotypic characteristics and exposure to UV radiation. The elevated rates of lung
cancer are suggestive for a role of tobacco as a cause of squamous cell skin cancer. Am J Epidemiol 1997;
146:734-9.
carcinoma, squamous cell; lung neoplasms; neoplasms, second primary; registries; salivary gland
neoplasms; skin; smoking; ultraviolet rays
Studies of multiple primary cancers have suggested
that subjects diagnosed with squamous cell skin cancer
(SCC) have increased incidence not only of other skin
cancers, but also of a wide spectrum of other neo-
plasms, particularly of squamous cell cancers of the
digestive and respiratory tract, of the salivary glands,
as well as of non-Hodgkin's lymphomas and other
lymphoid neoplasms (1-6). Thus, analysis of new
primary cancers following squamous cell skin cancer
have a public health and risk assessment interest, as
well as potential implications for etiologic inference.
The Cancer Registries of the French-speaking can-
tons of Vaud and Neuchatel, Switzerland, have been
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Abbreviations: Cl, confidence interval; ICD-O, International Clas-
sification of Diseases for Oncology; SCC, squamous cell skin can-
cer; SIR, standardized incidence ratio; UV radiation, ultraviolet ra-
diation.
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operating since 1972 in a particularly favorable envi-
ronment for skin cancer registration, because tradition-
ally the large majority of surgically resected cutaneous
lesions in the two cantons are examined by a pathol-
ogist (7, 8). As a consequence, a large series of squa-
mous cell skin neoplasms have been followed for a
uniquely long period of time. Previously, we have
reported an excess of non-Hodgkin's lymphomas, and
of chronic lymphocytic leukemia, in this data set (6).
Similar analyses extended to other neoplasms are now
presented here.
MATERIALS AND METHODS
Data for the present report were abstracted from the
Vaud and Neuchatel Cancer Registries files, which
include incident cases of malignant neoplasms in the
cantons (9, 10), whose populations, according to the
1990 Census, were about 602,000 and 164,000 inhab-
itants, respectively. In these cantons, cancer registra-
tion systems have been implemented since 1972, and
population-based incidence data have been available
since 1974. The registries are tumor-based, and mul-
tiple primaries in the same person are entered sepa-
rately. Most cases are registered repeatedly and from
different institutions, thus improving completeness
and accuracy of registration. Information from death
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certificates is routinely integrated in the data file; cases
known only through death certificates amount to fewer
than 5 percent of the average number of cases regis-
tered per year. Overall histologic confirmation and
completeness exceed 90 percent (9, 10).
The information available from the registries com-
prises sociodemographic characteristics of the patient
(i.e., age, sex), primary site and histologic type of the
tumor according to the standard International Classi-
fication of Diseases for Oncology (ICD-O) (11), and
date of diagnostic confirmation. Passive and active
follow-up is recorded, and each subsequent item of
information concerning an already registered case is
used to complete the record of that patient.
After exclusion of synchronous cancers (n = 56,
i.e., 50 basal cell and 1 melanoma skin cancers, 3
squamous cell carcinomas of the oropharynx, 1 small
cell carcinoma of the lung, and 1 adenocarcinoma of
the prostate), the present series comprises a total of
4,639 histologically confirmed squamous cell carcino-
mas of the skin (ICD-O topography: 173.0-173.9 and
morphology codes: 8051-2, 8070-6, 8094, 8560) di-
agnosed between 1974 and 1994. The age range was
8-102 years (median age, 74 years).
These cases of incident squamous cell skin carcino-
mas were followed to the end of 1994 for the occur-
rence of a second (other than SCC) primary cancer,
emigration, or death. As a rule of cancer registration in
Switzerland, SCCs (either synchronous or metachro-
nous) are registered only at the first recognized tumor
of the same morphologic type.
Calculation of expected numbers was based on site-,
age-, and calendar period-specific incidence rates from
the cancer registries, multiplied by the observed cor-
responding number of person-years at risk. The sig-
nificance of the observed/expected ratios (standard-
ized incidence ratios (SIR)), and the corresponding 95
percent confidence intervals, were based on the Pois-
son distribution (12). Cumulative rates were computed
using the life table approach (13).
RESULTS
Table 1 gives the distribution of 4,639 cases of
squamous cell skin cancer according to age, the cor-
responding incidence rates for the whole calendar pe-
riod, and the person-years at risk in separate strata of
time since diagnosis, for a total of 23,152 person-years
at risk.
Table 2 gives the observed and expected numbers of
all neoplasms, and of selected subsequent cancer sites.
Overall, 729 metachronous cancers were observed
versus 527.6 expected (SIR = 1.4, 95 percent confi-
dence interval (CI) 1.3-1.5). After exclusion of all
TABLE 1. Age distribution of 4,639 cases of squamous cell
carcinoma of the skin and corresponding incidence rates, and
person-years at risk by time since diagnosis, Vaud and
Neuchatel, Switzerland, 1974-1994*
Age group (years)
<30
30-39
40-^19
50-59
60-69
70-79
>80
Total, all ages
Time since
diagnosis (years)
<1
1-4
5-9
10-14
Total
No. of Incidence rate
cases per 100,000
Males
9
32
107
235
585
901
660
2,529
Females Males
5 0.3
27 2.8
97 10.7
185 29.0
375 92.6
646 221.2
775 424.2
2,110 21.6T
Person-years
at risk
4,209
11,064
5,814
2,065
23,152
Females
0.2
2.4
9.5
21.3
49.1
106.0
226.6
12.2t
* Denominators in 1980—Vaud, 529,000; Neuchatel, 158,000.
In 1990—Vaud, 602,000; Neuchatel, 164,000.
t Incidence rate age standardized on the world population.
other skin cancers, however, 384 second primary neo-
plasms were observed versus 397.2 expected (SIR =
1.0, 95 percent CI 0.9-1.1). Excesses were observed
for cancer of the lip (SIR = 3.1) and lung (SIR = 1.3),
for basal cell skin cancer (SIR = 4.3), skin melanoma
(SIR = 3.3), and non-Hodgkin's lymphomas (SIR =
1.7). Nonsignificant elevated rates were also observed
for cancers of the salivary gland (SIR = 4.3) and
Hodgkin's disease (SIR = 2.7).
Sites of second primaries showing significant ex-
cesses or meaningful patterns are further considered in
table 3 in separate strata for sex, age at squamous cell
skin cancer diagnosis, and time since diagnosis. The
excess rates of lung and other skin cancers and lym-
phatic neoplasms were similar for males and females,
but tended to be systematically higher below age 65
years. Thus, standardized incidence ratios for lung
cancer were 1.6 below age 65 years and 1.1 at age 265
years, while those for breast cancer were 1.5 and 0.8,
for prostate cancer 1.8 and 1.1, and for basal cell skin
cancer 7.5 and 3.6, respectively. Below age 65 years,
significantly elevated standardized incidence ratios
were also observed for Hodgkin's disease (SIR =
15.8) as well as for all neoplasms (SIR = 2.2, 95
percent CI 1.9-2.6). After excluding other skin neo-
plasms, the standardized incidence ratio for all neo-
plasms was 1.2 (95 percent CI 1.0-1.5) below age 65
Am J Epidemiol Vol. 146, No. 9, 1997
736 Levi et al.
TABLE 2. Observed and expected cases, and standardized incidence ratios (SIR) of selected*
subsequent cancer sites after an initial diagnosis of squamous cell carcinoma of the skin, and
corresponding overall standardized incidence ratios (SIR) and 95% confidence intervals (Cl),
Vaud and Neuchatel, Switzerland, 1974-1994
Sits ICD-9t
No. of cases
Observed Expected
Up
Salivary gland
Mouth or pharynx
Esophagus
Stomach
Colon
Rectum
Gallbladder
Pancreas
Lung
Skin, melanoma
Skin, basal cell
Breast (females)
Uterus, corpus
Prostate
Bladder
Kidney
Hodgkin's disease
Other lymphomas
Myeloma
Leukemias
Total, all sites
Total, minus skin$
140
142
141, 143-8
150
151
153
154
156
157
162
172
173
174
182
185
188
189
201
200,202
203
204-7
5
3
8
5
18
29
19
6
13
62
23
317
32
6
74
16
11
3
20
6
6
729
384
1.6
0.7
9.1
9.4
23.0
41.0
23.7
6.4
14.8
48.8
7.0
73.9
32.7
6.5
64.8
19.7
8.2
1.1
12.1
4.9
11.1
527.6
397.2
SIR
3.1
4.3
0.9
0.5
0.8
0.7
0.8
1.0
0.9
1.3
3.3
4.3
1.0
0.9
1.1
0.8
1.4
2.7
1.7
1.2
0.5
1.4
1.0
95% Cl
1.0-7.3
0.9-12.6
0.4-1.8
0.2-1.2
0.5-1.2
0.5-1.0
0.5-1.3
0.4-2.1
0.5-1.5
1.0-1.6
2.1-4.9
3.8-4.8
0.7-1.4
0.3-2.0
0.9-1.4
0.5-1.3
0.7-2.4
0.6-8.0
1.0-2.6
0.4-2.7
0.2-1.2
1.3-1.5
0.9-1.1
* Only one case each was observed for cancers of the nasal cavity, bones, testis, thyroid; no case of cervical
cancer was registered; 2 cases were observed for small intestine cancer (SIR = 1.8), 2 for liver (SIR = 0.3), 4 for
larynx (SIR = 0.9), 2 for soft tissue (SIR = 1.8), 3 for ovaries (SIR = 0.6), and 3 for brain and nerves (SIR = 1.1).
t ICD-9, International Classification of Diseases, 9th Revision.
i Basal cell carcinoma, malignant melanomas, and 5 other primary skin cancers (2 dermatofibrosarcomas, 2
sebaceous carcinomas, and 1 leiomyosarcoma) were excluded.
years, but 0.9 at ages ^65 years. After age 65 years,
significantly elevated standardized incidence ratios
were observed for non-Hodgkin's lymphomas (SIR =
1.9). With reference to time since squamous cell skin
cancer diagnosis, the SIR for basal cell skin cancer
was 8.5 <1 year after diagnosis, but remained elevated
after 1-4 and ^ 5 years since diagnosis (SIR = 3.4),
indicating that the excess rates cannot be attributed
only to increased surveillance in the few years after
skin cancer diagnosis. For skin melanoma, the stan-
dardized incidence ratios tended to increase with in-
creasing time since SCC (SIR = 1.3 for <1 year, 2.7
for 1-4 years, and 5.0 after ^ 5 years since diagnosis).
No consistent pattern of trend with time since SCC
was observed for any of the other neoplasms.
Cumulative incidence of basal cell skin cancer fol-
lowing a diagnosis of squamous cell cancer was also
estimated. A steady rise was evident up to 15 years
after squamous cell skin cancer, with cumulative rates
of 6 percent at 5 years, 11 percent at 10 years, and 17
percent at 15 years.
DISCUSSION
The present study is based on a long-term follow-up
of a large population-based series of squamous cell
skin cancers from a particularly well surveilled popu-
lation. The study is also, to our knowledge, based on
the largest to date number of person-years at risk
following SCC. It confirms that rates of a few defined
groups of neoplasms, including not only other skin
cancers, but also cancers of the salivary gland neo-
plasm and lung, and Hodgkin's and non-Hodgkin's
lymphomas, are increased among subjects diagnosed
with SCCs, and that the excess rates persist for >10
years after skin cancer diagnosis.
The excesses for basal cell carcinoma and mela-
noma of the skin following SCC were Likely attribut-
able to shared risk factors, i.e., common phenotypic
characteristics and exposure to sunshine and other
sources of UV radiation (8, 14-18). It is of interest
that the standardized incidence ratios remained ele-
vated several years after diagnosis, particularly for
Am J Epidemiol Vol. 146, No. 9, 1997
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melanoma, suggesting either an action on one of the
earliest stages of the process of carcinogenesis (19), or
the persistence of risk determinants and risk factor
exposures. Exposure to UV radiation may also ex-
plain, at least in part, the elevated rates of non-
Hodgkin's lymphomas, assuming that UV radiation
causes immunosuppression, although the issue is still
open to discussion (5, 6, 20)
The elevated risk of cancer of the salivary glands
after squamous cell skin cancer has been observed in
other data sets, and is therefore probably real (4,
21-23). The causes of cancer of salivary glands, apart
from a role of radiation (24) which has been associated
with squamous cell skin cancer, too, are largely unde-
fined. Thus, this association has been attributed to the
common embryologic origin of salivary glands and
skin from the ectodermal layer of the fetus, but the
issue is still open to debate (25).
More interesting and important is the association
between squamous cell cancer and lung cancer. This
has been observed in other series (4), and is consistent
with the evidence from case-control and cohort studies
indicating that smoking is a risk factor for SCC. Thus,
the relative risk of squamous cell skin cancer was 2.3
in a case-control study in the Montreal region (26), 2.6
in a case-control study carried out in Uruguay (27),
and 1.5 in the Nurses' Health Study cohort (16). Fur-
ther, in a cohort of subjects with prior skin cancers (1),
an excess of subsequent squamous cell, but not basal
cell skin cancers, was observed among current smok-
ers. Although the data are insufficient to draw causal
inferences, there is therefore suggestive evidence to
include SCC among tobacco-related neoplasms. Other
possible common risk factors, such as a fat-rich diet
(28), may also contribute to explain the association
observed.
The observation that the standardized incidence ra-
tios for several neoplasms, including breast and pros-
tate, were higher in subjects diagnosed with SCC
under age 65 years may reflect genetic susceptibility,
as well as a more extensive exposure to selected risk
factors at younger age. A similar observation was
made in a record linkage study from Denmark (4).
In conclusion, therefore, this study confirms that
subjects diagnosed with SCC, while not having a
substantial and significant excess risk of all subse-
quent neoplasms, show a few specific excesses for
selected cancer sites, particularly for cancers diag-
nosed below age 65 years. This may shed interesting
light on common etiologic and pathogenic factors.
Further, for subsequent (basal cell and malignant mel-
anoma) skin cancer the excess is so large and persis-
tent to indicate that preventive intervention and long-
term monitoring of skin lesions are required among
subjects with SCC, and particularly among those di-
agnosed at a younger age.
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